Caplin Point Laboratories share news, announcements and annual reports
NSE: CAPLIPOINTBSE: 524742Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 28 Oct 2026. Previous close ₹2,352.40.
28 Oct: open ₹2,352.00, high ₹2,377.10, low ₹2,330.00
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹17,960 Cr453rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 26.99
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 5.01
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.34%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 20.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 19.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 39,48950.3% delivered
Caplin Point Laboratories routine notices
196 filed, newest first. Page 2 of 4.
Feb 2024
27 Feb · Routine
19 Feb · Routine
10 Feb · Routine
5 Feb · Routine
Jan 2024
27 Jan · Routine
12 Jan · Routine
9 Jan · Routine
Dec 2023
21 Dec · Routine
18 Dec · Routine
16 Dec · Routine
1 Dec · Routine
Nov 2023
10 Nov · Routine
10 Nov · Routine
Oct 2023
Sep 2023
26 Sep · Routine
19 Sep · Routine
11 Sep · Routine
11 Sep · Routine
8 Sep · Routine
8 Sep · Routine
Aug 2023
31 Aug · Routine
17 Aug · Routine
11 Aug · Routine
7 Aug · Routine
1 Aug · Routine
Jul 2023
28 Jul · Routine
20 Jul · Routine
13 Jul · Routine
7 Jul · Routine
Jun 2023
22 Jun · Routine
13 Jun · Routine
12 Jun · Routine
9 Jun · Routine
8 Jun · Routine
May 2023
29 May · Routine
29 May · Routine
17 May · Routine
13 May · Routine
11 May · Routine
5 May · Routine
4 May · Routine
2 May · Routine
Apr 2023
22 Apr · Routine
13 Apr · Routine